Neural Predictors and Neural Changes Associated With Cognitive Behavior Therapy for Obssesive Compulsive Disorder
1 other identifier
interventional
120
1 country
3
Brief Summary
The goals of the project are 1) to understand what are the neural mechanisms involved in the psychological treatment of obsessive-compulsive disorder (OCD) in children/adolescents and adults, 2) to assess potential differences in the neural mechanisms involved in the psychological treatment of OCD between children/adolescents and adults, and 3) to assess the effectiveness of intensive CBT for children/adolescents and adults with OCD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2019
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2019
CompletedFirst Submitted
Initial submission to the registry
July 30, 2019
CompletedFirst Posted
Study publicly available on registry
August 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2023
CompletedMarch 1, 2023
February 1, 2023
4.1 years
July 30, 2019
February 28, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Yale-Brown Obsessive-Compulsive Scale
The Yale-Brown Obsessive-Compulsive Scale evaluates the severity of Obsessive Compulsive Disorder symptoms in adults. The scale is a clinician-rated, 10-item scale, each item rated from 0 (no symptoms) to 4 (extreme symptoms) (total range, 0 to 40), with separate subtotals for severity of obsessions and compulsions.
Change from baseline to post-treatment (1 month)
Children´s Yale-Brown Obsessive-Compulsive Scale
The Children´s Yale-Brown Obsessive-Compulsive Scale evaluates the severity of Obsessive Compulsive Disorder symptoms in children/adolescents. The severity of the obsessions is rated on five Severity Items for Obsessions. Each of these five items is rated on a 5-point, ordinal scale: 0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = extreme. These values are anchored by a description for each score. The Obsessions Severity Score is obtained by adding the scores for items 1 through 5 (range = 0 to 20). There are five comparable Severity Items for Compulsions (items 6 through 10), which are also scored from 0 to 4. The Compulsions Severity Score is obtained by adding the scores of items 6 through 10 (range = 0 to 20). Summing the scores for all 10 items yields the CY-BOCS Total score (range = 0 to 40).
Change from baseline to post-treatment (1 month)
Secondary Outcomes (4)
Obsessive-Compulsive Inventory-Revised
Change from baseline to post-treatment (1 month)
Obsessive Compulsive Inventory-Child Version
Change from baseline to post-treatment (1 month)
Children's Depression Inventory
Change from baseline to 1 month.
Spence Children's Anxiety Scale
Change from baseline to 1 month
Study Arms (2)
CBT
EXPERIMENTALIntensive CBT (20 sessions in 1 month)
Waiting-list
NO INTERVENTIONWaiting-list
Interventions
Participants will receive up to 20 hours of manualized and structured CBT based on exposure and response prevention by experienced clinicians
Eligibility Criteria
You may qualify if:
- Principal diagnosis of OCD;
- Y-BOCS or CYBOCS ≥ 16).
- No current psychotropic medication (except benzodiacepines for sleep). 4 ) Age between 8 and 17 years (Study 1) and between 18 and 60 years (Study 2).
You may not qualify if:
- Current major depression or current/past psychosis, bipolar disorder or substance abuse.
- Developmental disorders (including autistic spectrum disorders).
- To be pregnant or during breastfeeding
- Current CBT; nt.
- Any severe medical disorder ;
- Any contraindication for neuroimaging
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
IDIBELL
L'Hospitalet de Llobregat, Barcelona, 08907, Spain
FIDMAG Germanes Hospitalàries
Sant Boi de Llobregat, Barcelona, 08035, Spain
IDIBAPS
Barcelona, 08036, Spain
Related Publications (1)
Hermida-Barros L, Garcia-Delgar B, Lera-Miguel S, Forcadell E, Moreno E, Prime-Tous M, Jaurrieta N, Segu X, Vilajosana E, Soriano-Mas C, de la Cruz LF, Vieta E, Radua J, Lazaro L, Fullana MA. Concentrated Cognitive-Behavior Therapy for Unmedicated Children and Adolescents With Obsessive-Compulsive Disorder in Routine Clinical Care: A Randomized Controlled Trial With a 6-Month Naturalistic Follow-up. Behav Ther. 2025 Jul;56(4):799-811. doi: 10.1016/j.beth.2025.01.001. Epub 2025 Jan 13.
PMID: 40541379DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
July 30, 2019
First Posted
August 1, 2019
Study Start
May 1, 2019
Primary Completion
June 1, 2023
Study Completion
September 1, 2023
Last Updated
March 1, 2023
Record last verified: 2023-02